60 Degrees Pharmaceuticals Inc.

Last updated September 27, 2026

Organization details

Legal name
60 Degrees Pharmaceuticals Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
Washington
Headquarters state / province
District of Columbia
Headquarters country
United States
Fiscal year end
December
Ticker symbol
SXTP
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001946563
EIN
45-2406880

Board of directors

Chief executives

Geoffrey S. Dow · President and CEO
Since July 2023
100 CEO score

Outstanding · grade A+

Out of 100, from shareholder return, dividends, growth and acquisitions.

Partial: only 20% of the scoring weight is on file.

Revenue growth 20%
100

65.2% a year in revenue

20% of the scoring weight is on file. Figures cover December 2022 – December 2025.

Director election results

Annual meeting of July 16, 2024. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

1 of this board's directors also sit on 1 other board.

Network of 60 Degrees Pharmaceuticals Inc.'s board connections BTCS Inc. BTCS Inc. Charles W. Allen Charles W. Allen 60 Degrees Pharmaceuticals...
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$30,085
4 purchases by 1 insider
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Jun 12, 2026 Geoffrey S. Dow Director, Officer (President and CEO) Open-market purchase +7,350 $1.38 $10,143
Dec 15, 2025 Geoffrey S. Dow Director, Officer (President and CEO) Open-market purchase +9,670 $0.80 $7,736
Dec 11, 2025 Geoffrey S. Dow Director, Officer (President and CEO) Open-market purchase +3,613 $0.92 $3,324
Dec 10, 2025 Geoffrey S. Dow Director, Officer (President and CEO) Open-market purchase +9,350 $0.95 $8,883
Sep 12, 2025 Geoffrey S. Dow Director, Officer (President and CEO) Grant or award +7,201 $1.39 $10,009
Jun 9, 2025 Geoffrey S. Dow Director, Officer (President and CEO) Grant or award +4,376 $2.99 $13,084
Jun 3, 2025 Cheryl Xu Director Open-market purchase +3,000 $2.87 $8,610
Jun 3, 2025 Cheryl Xu Director Open-market purchase +2,000 $2.90 $5,800
Jan 17, 2025 Geoffrey S. Dow Director, Officer (President and CEO) Grant or award +14,394 — —
Jan 17, 2025 MILLER TYRONE Officer (CFO) Grant or award +11,626 — —
Jan 17, 2025 Landon Kristen Officer (Chief Operating Officer) Grant or award +4,540 — —
Dec 16, 2024 Cheryl Xu Director Open-market purchase +2,000 $1.45 $2,900
Dec 13, 2024 Cheryl Xu Director Open-market purchase +1,500 $1.60 $2,400
Dec 13, 2024 Cheryl Xu Director Open-market purchase +1,500 $1.58 $2,370
Dec 13, 2024 Cheryl Xu Director Open-market purchase +1,500 $1.55 $2,325

Organizations in the same sector, closest in location and size first.

Questions about 60 Degrees Pharmaceuticals Inc.

Who is the CEO of 60 Degrees Pharmaceuticals Inc.?

Geoffrey S. Dow has been 60 Degrees Pharmaceuticals Inc.'s President and CEO since July 2023.

How many directors are on 60 Degrees Pharmaceuticals Inc.'s board?

60 Degrees Pharmaceuticals Inc.'s board has 6 directors: Charles W. Allen, Cheryl Xu, Eric Francois, Geoffrey S. Dow, Paul Field and Stephen Toovey.

Are 60 Degrees Pharmaceuticals Inc. insiders buying or selling shares?

Over the last 12 months, 60 Degrees Pharmaceuticals Inc. insiders bought $30,085 of shares in 4 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="60-degrees-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.